Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application

Real-Time Quote  
Real-Time Quote Not Available Why not?
Real-Time Quote Only available during pre-market and regular market hours. about
  • Day Low  4.01 10:36 AM EST  
    Day High 4.20 09:31 AM EST
    Range 0.19  
    Volume 873,650  
    30-Day Avg Vol 1.10 M
    Difference -20.65%  
    Market Cap 328.30 M  
    Mkt Cap Chg -2.37 M  
    Shares Out 79.30 M  
    % Shrs Traded 1.10%  
    1yr EPS Est 0.62  
    52-Wk Low 3.29
    52-Wk High 7.66
    Range 4.37  
    Prev Close 4.17 11/5/09  
    Today's Open 4.16  
    Change -0.24%
    Dividend (TTM)  
    Div Yield (TTM)
    Ex-Div Date
    Div Date
    Short Interest 11.32 M

    Performance Details

    Revenue (LFY) 110.18 M  
    Earnings (LFY) 29.20 M  
    Earnings (MRQ) 11.94 M  
    Next Earn Est 0.17  
    Next Earnings 11/09/2009
    EPS (TTM) 0.56  
    1yr EPS Growth -16.22%  
    P/E Ratio (TTM) 6.90  
    P/E Ratio (Fwd) 6.60  
    PEG Ratio 0.94  
    Return on Equity 23.02  
    Beta 1.74  
    Sector Healthcare  
    Industry Drugs  
    Click icons above for more info
  • Set and Manage Alerts

    Alert me if
  • Blog Posts: AOB

    Blogs are not currently available for aob.

    View all blogs at BloggingStocks.

  • Related Information: AOB

    Company Overview: AOB

    American Oriental Bioengineering (AOBO) is firmly planted in the pharmaceutical industry. Through subsidiaries, AOBO makes more than 20 plant-based pharmaceuticals and nutraceuticals based on Traditional ... View Full Description

    Earnings Analysis: AOB

    Analyst Consensus

    • Strong Buy
    • Buy
    • Hold
    • Sell
    • Strong Sell
    Earnings/Share(EPS) Estimate Actual Difference
    Next Quarter 0.17 11/9/09
    Last Quarter 0.176 6/30/09 0.17 6/30/09 -0.006
    Missed
    2 Quarters Ago 0.118 3/31/09 0.11 3/31/09 -0.008
    Missed

    Financials: AOB

      Quarterly - 09/30/2007 Annual - 2006
    Total Revenue 43.51 M 110.18 M
    Gross Profit 30.30 M 68.51 M
    Operating Income 13.98 M 36.38 M
    Net Income 11.94 M 29.20 M